NO20025114D0 - Trombopoitein reseptor-modulerende peptid - Google Patents

Trombopoitein reseptor-modulerende peptid

Info

Publication number
NO20025114D0
NO20025114D0 NO20025114A NO20025114A NO20025114D0 NO 20025114 D0 NO20025114 D0 NO 20025114D0 NO 20025114 A NO20025114 A NO 20025114A NO 20025114 A NO20025114 A NO 20025114A NO 20025114 D0 NO20025114 D0 NO 20025114D0
Authority
NO
Norway
Prior art keywords
receptor modulating
thrombopoietin receptor
modulating peptide
peptide
thrombopoietin
Prior art date
Application number
NO20025114A
Other languages
English (en)
Other versions
NO20025114L (no
Inventor
Tatjana Naranda
Lennart Olsson
Original Assignee
Pliva Pharm & Chem Works
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Pharm & Chem Works filed Critical Pliva Pharm & Chem Works
Publication of NO20025114D0 publication Critical patent/NO20025114D0/no
Publication of NO20025114L publication Critical patent/NO20025114L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20025114A 2000-04-25 2002-10-24 Trombopoitein-reseptormodulerende peptid NO20025114L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00108075A EP1149906A1 (en) 2000-04-25 2000-04-25 Thrombopoietin receptor modulating peptide
PCT/EP2001/004553 WO2001080873A2 (en) 2000-04-25 2001-04-23 Thrombopoietin receptor modulating peptide

Publications (2)

Publication Number Publication Date
NO20025114D0 true NO20025114D0 (no) 2002-10-24
NO20025114L NO20025114L (no) 2002-12-18

Family

ID=8168467

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025114A NO20025114L (no) 2000-04-25 2002-10-24 Trombopoitein-reseptormodulerende peptid

Country Status (24)

Country Link
US (1) US20030181659A1 (no)
EP (2) EP1149906A1 (no)
JP (1) JP2003530867A (no)
KR (1) KR20030009450A (no)
CN (1) CN1426467A (no)
AR (1) AR030278A1 (no)
AU (2) AU6736601A (no)
BG (1) BG107214A (no)
BR (1) BR0110383A (no)
CA (1) CA2407167A1 (no)
CZ (1) CZ20023517A3 (no)
EA (1) EA006423B1 (no)
EE (1) EE200200610A (no)
GE (1) GEP20063763B (no)
HU (1) HUP0300559A3 (no)
IL (1) IL152204A0 (no)
IS (1) IS6582A (no)
MX (1) MXPA02010458A (no)
NO (1) NO20025114L (no)
PL (1) PL358304A1 (no)
SK (1) SK15262002A3 (no)
WO (1) WO2001080873A2 (no)
YU (1) YU79202A (no)
ZA (1) ZA200208662B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005508173A (ja) * 2001-11-07 2005-03-31 ミレニアム・ファーマシューティカルズ・インコーポレイテッド 232、2059、10630、12848、13875、14395、14618、17692または58874を使用する血液障害を処置するための方法および組成物
US7923431B2 (en) * 2001-12-21 2011-04-12 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
US8067367B2 (en) * 2002-09-18 2011-11-29 Janssen Pharmaceutica, N.V. Methods of increasing platelet and hematopoietic stem cell production
EP1573295A2 (en) 2002-12-11 2005-09-14 Ferrosan A/S Gelatine-based materials as swabs
CA2525464A1 (en) * 2003-05-12 2004-11-25 Qun Yin Novel poly(ethylene glycol) modified compounds and uses thereof
NZ543934A (en) * 2003-05-12 2008-06-30 Affymax Inc Novel spacer moiety for poly (ethylene glycol)-modified peptide-based compounds
JP2005187435A (ja) * 2003-12-26 2005-07-14 Otsuka Chemical Co Ltd 血小板産生促進組成物
EP1713521B1 (en) 2004-01-30 2010-07-28 Ferrosan A/S Haemostatic sprays and compositions
RU2369408C2 (ru) 2004-07-09 2009-10-10 Ферросан А/С Гемостатическая композиция, включающая гиалуроновую кислоту
ES2373989T3 (es) * 2006-01-31 2012-02-10 Mitsubishi Chemical Medience Corporation Procedimiento para la determinación del estado de un síndrome de coagulación intravascular diseminada.
EP2259803B2 (en) 2008-02-29 2019-03-13 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
ES2659262T3 (es) * 2011-05-13 2018-03-14 The University Of Tokyo Célula megacariocítica polinucleada y método para la elaboración de plaquetas
RU2657955C2 (ru) 2012-03-06 2018-06-18 Ферросан Медикал Дивайсиз А/С Контейнер под давлением, содержащий гемостатическую пасту
JP6394916B2 (ja) 2012-06-12 2018-09-26 フェロサン メディカル デバイシーズ エイ/エス 乾燥止血組成物
US9724078B2 (en) 2013-06-21 2017-08-08 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
CA2928963C (en) 2013-12-11 2020-10-27 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
CA2960309A1 (en) 2014-10-13 2016-04-21 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
JP6747650B2 (ja) 2014-12-24 2020-08-26 フェロサン メディカル デバイシーズ エイ/エス 第1の物質と第2の物質を保持し混合するためのシリンジ
BR112017027695A2 (pt) 2015-07-03 2018-09-04 Ferrosan Medical Devices As seringa para retenção e mistura de primeira e segunda substâncias
CN112368028A (zh) 2018-05-09 2021-02-12 弗罗桑医疗设备公司 用于制备止血组合物的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5498599A (en) * 1994-01-21 1996-03-12 Amgen Inc. Methods for stimulating platelet production
WO1996040189A1 (en) * 1995-06-07 1996-12-19 Glaxo Group Limited Peptides and compounds that bind to a receptor
US6342220B1 (en) * 1997-08-25 2002-01-29 Genentech, Inc. Agonist antibodies
JP2002508160A (ja) * 1998-02-24 2002-03-19 レセプトロン,インコーポレイティド 受容体活性のモジュレーターとしての受容体由来ペプチド

Also Published As

Publication number Publication date
AU2001267366B2 (en) 2005-06-30
SK15262002A3 (sk) 2003-05-02
BG107214A (bg) 2003-11-28
AU6736601A (en) 2001-11-07
BR0110383A (pt) 2003-01-21
AU2001267366B9 (en) 2005-07-14
EE200200610A (et) 2004-08-16
WO2001080873A2 (en) 2001-11-01
HUP0300559A3 (en) 2005-09-28
WO2001080873A3 (en) 2002-01-31
US20030181659A1 (en) 2003-09-25
AR030278A1 (es) 2003-08-20
EA200201138A1 (ru) 2003-06-26
EP1149906A1 (en) 2001-10-31
ZA200208662B (en) 2003-10-27
KR20030009450A (ko) 2003-01-29
GEP20063763B (en) 2006-03-10
EP1278849A2 (en) 2003-01-29
YU79202A (sh) 2006-01-16
HUP0300559A2 (hu) 2003-06-28
CZ20023517A3 (cs) 2003-10-15
CN1426467A (zh) 2003-06-25
PL358304A1 (en) 2004-08-09
NO20025114L (no) 2002-12-18
IL152204A0 (en) 2003-05-29
IS6582A (is) 2002-10-14
EA006423B1 (ru) 2005-12-29
JP2003530867A (ja) 2003-10-21
CA2407167A1 (en) 2001-11-01
MXPA02010458A (es) 2003-06-06

Similar Documents

Publication Publication Date Title
NO20025114L (no) Trombopoitein-reseptormodulerende peptid
NO20071303L (no) Farmasoytiske preparater
DE50112149D1 (de) MRAM-Anordnung
DE60113887T2 (de) Projektor
ATE252915T1 (de) Formulierung zur verzögerten freisetzung von peptiden
DE50115474D1 (de) Piezoelektrisch erregbares schwingelement
DE60122873D1 (de) Therapeutische porenbildende peptide
DE50112432D1 (de) MRAM-Anordnung
NO20025817L (no) Oligopeptider
DE50009946D1 (de) Schädlingsbekämpfungsmittel/depsipeptide
NO20024322D0 (no) Sekvens
DE60112167D1 (de) Vibrator
DE60138276D1 (de) Projektor
DE60334194D1 (de) Transmembranes nfat-hemmendes peptid
FR2791348B1 (fr) POLYPEPTIDE Npt2B
ATA4432000A (de) Streugerät
NO20032963D0 (no) Peptidforbindelser
DE60131849D1 (de) Sprühvorrichtung
DE50106006D1 (de) Streugerät
DE50012174D1 (de) Winkelschleifer
NO20013933D0 (no) Peptider
DE50015362D1 (de) Winkelschleifer
SE0001833D0 (sv) Peptidkonjugat
NO20020794L (no) Meg-1-protein
NO20016188D0 (no) BH3 modifiserte peptider

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application